Cargando…
Identification of Risk Factors for Daptomycin-Associated Creatine Phosphokinase Elevation and Development of a Risk Prediction Model for Incidence Probability
BACKGROUND: In this study, we investigated the risk factors for daptomycin-associated creatine phosphokinase (CPK) elevation and established a risk score for CPK elevation. METHODS: Patients who received daptomycin at our hospital were classified into the non-elevated or elevated CPK group based on...
Autores principales: | Samura, Masaru, Hirose, Naoki, Kurata, Takenori, Takada, Keisuke, Nagumo, Fumio, Koshioka, Sakura, Ishii, Junichi, Uchida, Masaki, Inoue, Junki, Enoki, Yuki, Taguchi, Kazuaki, Higashita, Ryuji, Kunika, Norifumi, Tanikawa, Koji, Matsumoto, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651170/ https://www.ncbi.nlm.nih.gov/pubmed/34888403 http://dx.doi.org/10.1093/ofid/ofab568 |
Ejemplares similares
-
A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19
por: Takada, Keisuke, et al.
Publicado: (2022) -
PLASMA CREATINE PHOSPHOKINASE IN SCHIZOPHRENIA
por: Kondaiah, P., et al.
Publicado: (1981) -
A Retrospective Multisite Case-Control Series of Concomitant Use of Daptomycin and Statins and the Effect on Creatine Phosphokinase
por: Lehman, Bethany, et al.
Publicado: (2019) -
Creatine phosphokinase elevation exacerbated by levetiracetam therapy
por: Isaacson, Julia E., et al.
Publicado: (2014) -
ELEVATED CREATINE PHOSPHOKINASE IN PATIENTS WITH COVID-19
por: BHALLA, SUSHEN, et al.
Publicado: (2022)